(Q36269233)

13 August 2017

1 reference

title

Linezolid treatment of ventriculoperitoneal shunt infection without implant removal (English)

1 reference

13 August 2017

1 reference

Castro P

1

1 reference

13 August 2017

Soriano A

2

1 reference

13 August 2017

Escrich C

3

1 reference

13 August 2017

Villalba G

4

1 reference

13 August 2017

Sarasa M

5

1 reference

13 August 2017

Mensa J

6

1 reference

13 August 2017

publication date

1 September 2005

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

13 August 2017

published in

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

603-606

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-005-0015-9

13 August 2017

exact match

0 references

cites work

Hydrocephalus shunt infections

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10096-005-0015-9

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid

21 January 2018

1 reference

12 December 2020

Treatment of Staphylococcus epidermidis ventriculo-peritoneal shunt infection with linezolid

1 reference

12 December 2020

Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).

1 reference

12 December 2020

Bacterial adhesion to cerebrospinal fluid shunts

1 reference

12 December 2020

Infection of cerebrospinal fluid shunts in infants: a study of etiological factors.

1 reference

12 December 2020

Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens

1 reference

12 December 2020

Sensorineural hearing loss associated with intrathecal vancomycin

1 reference

12 December 2020

CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.

1 reference

12 December 2020

The management of cerebrospinal fluid shunt infections: a clinical experience

1 reference

12 December 2020

Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience

1 reference

12 December 2020

Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis

1 reference

12 December 2020

Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome

1 reference

12 December 2020

Linezolid for the treatment of central nervous system infections in neurosurgical patients

1 reference

12 December 2020

Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid

1 reference

12 December 2020

An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model

1 reference

12 December 2020

Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts

1 reference

12 December 2020

Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts

1 reference

12 December 2020

Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria

1 reference

12 December 2020

Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature

1 reference

12 December 2020

Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy

1 reference

12 December 2020

10.1007/S10096-005-0015-9

Identifiers

DOI

1 reference

13 August 2017

1 reference